Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands
INTRODUCTION AND BACKGROUND: A tetravalent DNA vaccine for Dengue virus is under development but has not yet achieved optimal immunogenicity. Salivary glands vaccination has been reported efficacious in rodents and dogs. We report on a pilot study testing the salivary gland as a platform for a Dengu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268334/ https://www.ncbi.nlm.nih.gov/pubmed/32518668 http://dx.doi.org/10.1186/s40794-020-00111-5 |
_version_ | 1783541594911145984 |
---|---|
author | El Helou, Guy Ponzio, Todd A. Goodman, Joseph F. Blevins, Maria Caudell, David L. Raviprakash, Kanakatte S. Ewing, Daniel Williams, Maya Porter, Kevin R. Sanders, John W. |
author_facet | El Helou, Guy Ponzio, Todd A. Goodman, Joseph F. Blevins, Maria Caudell, David L. Raviprakash, Kanakatte S. Ewing, Daniel Williams, Maya Porter, Kevin R. Sanders, John W. |
author_sort | El Helou, Guy |
collection | PubMed |
description | INTRODUCTION AND BACKGROUND: A tetravalent DNA vaccine for Dengue virus is under development but has not yet achieved optimal immunogenicity. Salivary glands vaccination has been reported efficacious in rodents and dogs. We report on a pilot study testing the salivary gland as a platform for a Dengue DNA vaccine in a non-human primate model. MATERIALS AND METHODS: Four cynomolgus macaques were used in this study. Each macaque was pre-medicated with atropine and sedated with ketamine. Stensen’s duct papilla was cannulated with a P10 polyethylene tube, linked to a 500ul syringe. On the first two infusions, all macaques were infused with 300ul of TVDV mixed with 2 mg of zinc. For the 3rd infusion, to increase transfection into salivary tissue, two animals received 100uL TVDV mixed with 400uL polyethylenimine 1μg/ml (PEI) and the other two animals received 500uL TVDV with zinc. Antibody titers were assessed 4 weeks following the second and third infusion. RESULTS AND CONCLUSIONS: SGRI through Stensen’s duct is a well-tolerated, simple and easy to reproduce procedure. TVDV infused into macaques salivary glands elicited a significantly weaker antibody response than with different delivery methods. |
format | Online Article Text |
id | pubmed-7268334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72683342020-06-08 Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands El Helou, Guy Ponzio, Todd A. Goodman, Joseph F. Blevins, Maria Caudell, David L. Raviprakash, Kanakatte S. Ewing, Daniel Williams, Maya Porter, Kevin R. Sanders, John W. Trop Dis Travel Med Vaccines Short Report INTRODUCTION AND BACKGROUND: A tetravalent DNA vaccine for Dengue virus is under development but has not yet achieved optimal immunogenicity. Salivary glands vaccination has been reported efficacious in rodents and dogs. We report on a pilot study testing the salivary gland as a platform for a Dengue DNA vaccine in a non-human primate model. MATERIALS AND METHODS: Four cynomolgus macaques were used in this study. Each macaque was pre-medicated with atropine and sedated with ketamine. Stensen’s duct papilla was cannulated with a P10 polyethylene tube, linked to a 500ul syringe. On the first two infusions, all macaques were infused with 300ul of TVDV mixed with 2 mg of zinc. For the 3rd infusion, to increase transfection into salivary tissue, two animals received 100uL TVDV mixed with 400uL polyethylenimine 1μg/ml (PEI) and the other two animals received 500uL TVDV with zinc. Antibody titers were assessed 4 weeks following the second and third infusion. RESULTS AND CONCLUSIONS: SGRI through Stensen’s duct is a well-tolerated, simple and easy to reproduce procedure. TVDV infused into macaques salivary glands elicited a significantly weaker antibody response than with different delivery methods. BioMed Central 2020-06-03 /pmc/articles/PMC7268334/ /pubmed/32518668 http://dx.doi.org/10.1186/s40794-020-00111-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Short Report El Helou, Guy Ponzio, Todd A. Goodman, Joseph F. Blevins, Maria Caudell, David L. Raviprakash, Kanakatte S. Ewing, Daniel Williams, Maya Porter, Kevin R. Sanders, John W. Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands |
title | Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands |
title_full | Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands |
title_fullStr | Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands |
title_full_unstemmed | Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands |
title_short | Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands |
title_sort | tetravalent dengue dna vaccine is not immunogenic when delivered by retrograde infusion into salivary glands |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268334/ https://www.ncbi.nlm.nih.gov/pubmed/32518668 http://dx.doi.org/10.1186/s40794-020-00111-5 |
work_keys_str_mv | AT elhelouguy tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands AT ponziotodda tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands AT goodmanjosephf tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands AT blevinsmaria tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands AT caudelldavidl tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands AT raviprakashkanakattes tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands AT ewingdaniel tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands AT williamsmaya tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands AT porterkevinr tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands AT sandersjohnw tetravalentdenguednavaccineisnotimmunogenicwhendeliveredbyretrogradeinfusionintosalivaryglands |